ANGO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
AngioDynamics Inc (ANGO) is not a strong buy at this moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock lacks clear positive trading signals, recent news catalysts, or strong financial performance to justify immediate action. Holding or waiting for further developments is recommended.
The stock shows mixed technical indicators. The MACD is positive but contracting, RSI is neutral at 59.868, and moving averages are converging, indicating no clear trend. Key support and resistance levels are at S1: 10.059 and R1: 11.499, suggesting limited upside potential in the short term.
Revenue growth of 9.04% YoY in the latest quarter and an increase in gross margin to 53.05% are positive signs of operational efficiency.
Net income dropped significantly by -40.86% YoY, and EPS fell by -42.31% YoY, indicating weak profitability. Additionally, no recent news or significant trading trends from hedge funds, insiders, or Congress adds to the lack of momentum.
In Q2 2026, revenue increased to $79.43M (up 9.04% YoY), but net income dropped to -$6.35M (-40.86% YoY), and EPS declined to -0.15 (-42.31% YoY). Gross margin improved to 53.05% (up 3.47% YoY), showing operational efficiency but weak profitability.
No recent analyst ratings or price target changes are available for evaluation.
